Clinical Trial Update: Pioglitazone Versus Empagliflozin for Chronic Pancreatitis/Recurrent Acute Pancreatitis Associated Diabetes Mellitus [Phase 2]

View source ↗

Summary

Phase 2 clinical trial comparing pioglitazone to empagliflozin for diabetes associated with chronic pancreatitis and recurrent acute pancreatitis; currently rec…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus
• Pancreatitis

Drugs mentioned

• Actos (pioglitazone) (pioglitazone)
• Jardiance (empagliflozin) (empagliflozin)

Snippet

Sponsor: Mayo Clinic | Conditions: Pancreatitis, Chronic, Pancreatitis, Acute | Phase 2 | Status: RECRUITING